At a glance
ClinicalIndex Comparison RecordN/AWithdrawn· 0 enrolled
Drug / intervention
Dietary interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Physicians Committee for Responsible Medicine, A Randomized, Crossover Trial of the Effect of a Dietary Intervention on Intracellular Lipid, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes
Physicians Committee for Responsible Medicine·interventional·Posted Sep 13, 2019·Updated Jun 27, 2025
In Brief
A clinical study evaluating Dietary intervention for Diabetes Mellitus, Type 2. Withdrawn before enrollment, across 1 site.
Signals
Trial was withdrawn before enrollment
Detailed Summary
The purpose of this study is to compare the effects of a low-fat, plant-based dietary intervention and a portion-controlled dietary intervention (compliant with current American Diabetes Association (ADA) guidelines) on changes in intramyocellular and hepatocellular lipid content in adults with type 2 diabetes. Changes in insulin sensitivity and glycemic control will also be assessed in this study. The study duration is 44 weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesUnited States
CollaboratorsYale University
Timeline
N/AWithdrawnFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartJul 2025
Primary CompletionJul 2026
TodayJul 2026
First PostedSep 13, 2019
Enrollment StartJul 1, 2025
Primary CompletionJul 1, 2026
TodayJul 1, 2026
Enrollment to primary: 1 yearPosted 6.8 years ago
Interventions
Dietary interventionbehavioral
Low-fat, plant-based diet and a portion-controlled diet